Evidence map›Paper›PMID 29935219›Full record

Trial reportThe Journal of allergy and clinical immunology2019

Patients with common variable immunodeficiency with autoimmune cytopenias exhibit hyperplastic yet inefficient germinal center responses.

Neil Romberg, Carole Le Coz, Salomé Glauzy, Jean-Nicolas Schickel, Melissa Trofa, Brian E Nolan, Michele Paessler, Mina L Xu, Michele P Lambert, Saquib A Lakhani and 10 more

Open access · bronzeAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in The Journal of allergy and clinical immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Failure of B Cell Tolerance in CVID.Frontiers in immunology · 2019
    Trial
  4. Coexistent alterations of BAFF and B-cell phenotypes in complicated CVID course.The Journal of allergy and clinical immunology · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. T follicular helper cells in primary immune regulatory disorders.The Journal of allergy and clinical immunology · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. [Autoimmunity and Freiburg classification in common variable immunodeficiency].Revista medica del Instituto Mexicano del Seguro Social · 2023
    Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 1 country.

Neil RombergDivision of Immunology and Allergy, Children's Hospital of Philadelphia, Philadelphia, Pa; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pa. Electronic address: rombergn@email.chop.edu.
Carole Le CozDivision of Immunology and Allergy, Children's Hospital of Philadelphia, Philadelphia, Pa.
Salomé GlauzyDepartment of Immunobiology, Yale University School of Medicine, New Haven, Conn.
Jean-Nicolas SchickelDepartment of Immunobiology, Yale University School of Medicine, New Haven, Conn.
Melissa TrofaDivision of Immunology and Allergy, Children's Hospital of Philadelphia, Philadelphia, Pa.
Brian E NolanDivision of Rheumatology, Children's Hospital of Philadelphia, Philadelphia, Pa.
Michele PaesslerDivision of Hematopathology, Children's Hospital of Philadelphia, Philadelphia, Pa; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pa.
Mina L XuDepartment of Pathology, Yale University School of Medicine, New Haven, Conn.
Michele P LambertDivision of Hematology, Children's Hospital of Philadelphia, Philadelphia, Pa; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pa.
Saquib A LakhaniDepartment of Pediatrics, Yale University School of Medicine, New Haven, Conn; Pediatric Genomics Discovery Program, Yale University School of Medicine, New Haven, Conn.
Mustafa K KhokhaDepartment of Pediatrics, Yale University School of Medicine, New Haven, Conn; Department of Genetics, Yale University School of Medicine, New Haven, Conn; Pediatric Genomics Discovery Program, Yale University School of Medicine, New Haven, Conn.
Soma JyonouchiDivision of Immunology and Allergy, Children's Hospital of Philadelphia, Philadelphia, Pa; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pa.
Jennifer HeimallDivision of Immunology and Allergy, Children's Hospital of Philadelphia, Philadelphia, Pa; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pa.
Patricia TakachDepartment of Medicine, Division of Allergy and Immunology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pa.
Paul J MaglioneDivision of Clinical Immunology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
Jason CatanzaroDepartment of Pediatrics, Yale University School of Medicine, New Haven, Conn.
F Ida HsuDepartment of Medicine, Yale University School of Medicine, New Haven, Conn.
Kathleen E SullivanDivision of Immunology and Allergy, Children's Hospital of Philadelphia, Philadelphia, Pa; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pa.
Charlotte Cunningham-RundlesDivision of Clinical Immunology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
Eric MeffreDepartment of Immunobiology, Yale University School of Medicine, New Haven, Conn; Department of Medicine, Yale University School of Medicine, New Haven, Conn. Electronic address: eric.meffre@yale.edu.
Yale University · USChildren's Hospital of Philadelphia · USUniversity of Pennsylvania · USIcahn School of Medicine at Mount Sinai · US

Funding

Regulation of IgA class switching in the intestinal mucosaP01AI061093 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI MEFFRE, ERIC · 2004 to 2021
$29.8M
Loss of B Cell Tolerance in Rheumatoid ArthritisR01AI071087 · NIAID · YALE UNIVERSITY · PI MEFFRE, ERIC · 2006 to 2016
$4.3M
Yale Autoimmunity Center of ExcellenceU19AI082713 · NIAID · YALE UNIVERSITY · PI CHO, JUDY H. · 2009 to 2013
$3.6M
Role of B cell activating factor in non-infectious complications of common variable immunodeficiencyK23AI137183 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MAGLIONE, PAUL JOSEPH · 2018 to 2022
$945k
BLOCKING AUTOANTIBODY SECRETION IN CVID PATIENTS WITH ITP BY IL-2 RESTORED TREGSK23AI115001 · NIAID · YALE UNIVERSITY · PI ROMBERG, NEIL DAVID · 2015 to 2019
$909k
NIAID NIH HHS K23 AI115001NIAID NIH HHS K23 AI137183NIAID NIH HHS P01 AI061093NIAID NIH HHS R01 AI071087NIAID NIH HHS U19 AI082713
6 · The paper itself

Abstract

backgroundThe lack of pathogen-protective, isotype-switched antibodies in patients with common variable immunodeficiency (CVID) suggests germinal center (GC) hypoplasia, yet a subset of patients with CVID is paradoxically affected by autoantibody-mediated autoimmune cytopenias (AICs) and lymphadenopathy.

objectiveWe sought to compare the physical characteristics and immunologic output of GC responses in patients with CVID with AIC (CVID+AIC) and without AIC (CVID-AIC).

methodsWe analyzed GC size and shape in excisional lymph node biopsy specimens from 14 patients with CVID+AIC and 4 patients with CVID-AIC. Using paired peripheral blood samples, we determined how AICs specifically affected B-and T-cell compartments and antibody responses in patients with CVID.

resultsWe found that patients with CVID+AIC displayed irregularly shaped hyperplastic GCs, whereas GCs were scarce and small in patients with CVID-AIC. GC hyperplasia was also evidenced by an increase in numbers of circulating follicular helper T cells, which correlated with decreased regulatory T-cell frequencies and function. In addition, patients with CVID+AIC had serum endotoxemia associated with a dearth of isotype-switched memory B cells that displayed significantly lower somatic hypermutation frequencies than their counterparts with CVID-AIC. Moreover, IgG

conclusionsPatients with CVID+AIC do not contain mucosal microbiota and exhibit hyperplastic yet inefficient GC responses that favor the production of untolerized IgG

Indexed as

AdolescentAdultAgedAutoantibodiesBiopsyB-LymphocytesChildCommon Variable ImmunodeficiencyFemaleGerminal CenterHumansHyperplasiaImmunoglobulin GMaleMiddle AgedT-LymphocytesAutoantibodiesImmunoglobulin Gautoimmune cytopeniasB-cell tolerancecommensal bacteriaCommon variable immunodeficiencyfollicular helper T cellgerminal center responsesregulatory T cellsomatic hypermutation

Identifiers

PMID29935219
PMCPMC6400323
OpenAlexW2809104512

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.